Skip to main content

Advertisement

Log in

Hepatitis B virus surface antigen seroconversion after pegylated interferon-alpha treatment in an HIV-infected individual with chronic hepatitis B

  • Correspondence
  • Published:
Infection Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol. 2006;44:S6–9.

    Article  PubMed  Google Scholar 

  2. Wursthorn K, Buggisch P, Lutgehetmann M, et al. Temporary HBV resolution in an HIV-coinfected patient during HBV-directed combination therapy followed by relapse of HBV. Antivir. Ther. 2006;11:647–52.

    PubMed  CAS  Google Scholar 

  3. Soriano V, Puoti M, Peters M, et al. Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV–Hepatitis B Virus International Panel. AIDS. 2008;22:1399–410.

    Article  PubMed  Google Scholar 

  4. Konopnicki D, Mocroft A, de Wit S, et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDAcohort. AIDS. 2005;19:593–601.

    Article  PubMed  Google Scholar 

  5. Martín-Carbonero L, Teixeira T, Soriano V, et al. Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues. AIDS. 2011;25:73–9.

    Google Scholar 

  6. Gozlan J, Lacombe K, Gault E, et al. Complete cure of HBV-HDV co-infection after 24 weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV. J Hepatol. 2009;50:432–4.

    Article  PubMed  CAS  Google Scholar 

  7. Wölfel T, Schirmacher P, Schlaak J, et al. Sustained elimination of hepatitis B virus from serum induced in a patient with chronic hepatitis B and advanced human immunodeficiency virus infection. Clin Invest. 1994;72:1030–6.

    Article  PubMed  Google Scholar 

  8. Núñez M, Ramos B, Díaz-Pollán B, et al. Virological outcome of chronic hepatitis B virus infection in HIV-coinfected patients receiving anti-HBV active antiretroviral therapy. AIDS Res Hum Retroviruses. 2006;22:842–8.

    Article  PubMed  Google Scholar 

  9. Kalams SA, Walker BD. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J Exp Med. 1998;188:2199–204.

    Article  PubMed  CAS  Google Scholar 

  10. Psevdos G Jr, Kim JH, Suh JS, et al. Predictors of loss of hepatitis B surface antigen in HIV-infected patients. World J Gastroenterol. 2010;16:1093–6.

    Article  PubMed  Google Scholar 

  11. Brunetto MR. A new role for an old marker, HBsAg. J Hepatol. 2010;52:475–7.

    Article  PubMed  CAS  Google Scholar 

  12. Marcellin P, Boyer N, Colin J, et al. Recombinant α interferon for chronic hepatitis B in anti-HIV positive patients receiving zidovudine. Gut. 1993;34:S106.

    Article  PubMed  CAS  Google Scholar 

  13. Di Martino V, Thevenot T, Colin J, et al. Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B. Gastroenterology. 2002;123:1812–22.

    Article  PubMed  Google Scholar 

  14. Rockstroh JK, Bhagani S, Benhamou Y, et al. EACS Executive Committee European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. HIV Med. 2008;9:82–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. Rossetti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rossetti, B., Bianco, C. & De Luca, A. Hepatitis B virus surface antigen seroconversion after pegylated interferon-alpha treatment in an HIV-infected individual with chronic hepatitis B. Infection 40, 347–349 (2012). https://doi.org/10.1007/s15010-011-0198-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-011-0198-1

Keywords

Navigation